Literature DB >> 12848915

[The application of indirect immuno-fluorescence assay in the diagnosis of severe acute respiratory syndrome].

Li-qun Fang1, Pan-he Zhang, Bao-an Yang, Xiao-ming Wu, Qiu-min Zhao, Wei Liu, Hong Liu, Yong-qiang Deng, Lin Zhan, Wei-guo Han, Fu-shuang Lu, Jin-song Wu, Hong Yang, Qing-yu Zhu, Wu-chun Cao.   

Abstract

OBJECTIVE: To explore the temporal profile of serum antibody against coronavirus in patients with severe acute respiratory syndrome (SARS), and to evaluate the reliability of indirect immuno-fluorescence assay (IFA) in the diagnosis of SARS.
METHODS: Clinically confirmed SARS patients, suspected SARS patients, and controls were included in the study. IFA was used to detect the serum antibody against SARS coronavirus. General information about the subjects was collected using a standard questionnaire.
RESULTS: The positive rates of specific IgG and IgM against SARS virus within 10 days after onset of the disease were 55.1% and 16.3% respectively and then increased up to 89.8% for IgG and 65.3% for IgM. After 25 days of the onset of the disease, 90.9% patients became positive for both IgG and IgM. Results from chi-square for trend test revealed that the positive rates of both IgG and IgM increased with time (chi(2) for trend = 16.376, P = 0.00005 for IgG; chi(2) for trend = 28.736, P = 0.00000 for IgM). Sensitivity, specificity and agreement value of IFA regarding the diagnosis of SARS were all higher than 90%.
CONCLUSION: IFA can be used to assist diagnosis of SARS after 10 days of the onset of disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12848915

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  5 in total

1.  The laboratory diagnosis of severe acute respiratory syndrome: emerging laboratory tests for an emerging pathogen.

Authors:  Susan E Richardson; Raymond Tellier; James Mahony
Journal:  Clin Biochem Rev       Date:  2004-05

Review 2.  Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children.

Authors:  C W Leung; W K Chiu
Journal:  Paediatr Respir Rev       Date:  2004-12       Impact factor: 2.726

3.  Coupling multiplex RT-PCR to a gene chip assay for sensitive and semiquantitative detection of severe acute respiratory syndrome-coronavirus.

Authors:  Jyh-Lyh Juang; Tsan-Chi Chen; Shih Sheng Jiang; Chao A Hsiung; Wei-Chen Chen; Guang-Wu Chen; Shiang-Ming Lin; Jih-Hui Lin; Shu-Chun Chiu; Yiu-Kay Lai
Journal:  Lab Invest       Date:  2004-09       Impact factor: 5.662

4.  Emergency medical services utilization during an outbreak of severe acute respiratory syndrome (SARS) and the incidence of SARS-associated coronavirus infection among emergency medical technicians.

Authors:  Patrick Chow-In Ko; Wen-Jone Chen; Matthew Huei-Ming Ma; Wen-Chu Chiang; Chan-Ping Su; Chien-Hua Huang; Tsung-Chien Lu; Fuh-Yuan Shih; Fang-Yue Lin
Journal:  Acad Emerg Med       Date:  2004-09       Impact factor: 3.451

5.  Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).

Authors:  Te-hui W Chou; Shixia Wang; Pavlo V Sakhatskyy; Innocent Mboudjeka; Innocent Mboudoudjeck; John M Lawrence; Song Huang; Scott Coley; Baoan Yang; Jiaming Li; Qingyu Zhu; Shan Lu
Journal:  Virology       Date:  2005-03-30       Impact factor: 3.616

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.